<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Animal Health on FinanClub</title>
    <link>https://finan.club/tags/animal-health/</link>
    <description>Recent content in Animal Health on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Mon, 22 Jan 2024 09:05:50 +0000</lastBuildDate><atom:link href="https://finan.club/tags/animal-health/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>MRK</title>
      <link>https://finan.club/us/mrk/</link>
      <pubDate>Mon, 22 Jan 2024 09:05:50 +0000</pubDate>
      
      <guid>https://finan.club/us/mrk/</guid>
      <description>score:153
Chances: Merck &amp;amp; Co., Inc. has a strong portfolio of pharmaceutical, vaccine, and animal health products, positioning it well for future growth and profitability. The recent FDA approval for expanded use of Keytruda in combination with chemoradiotherapy for advanced cervical cancer is a significant positive development for the company.</description>
    </item>
    
  </channel>
</rss>
